New pill shows promise against Hard-to-Treat cancers
Disease control
Ongoing
This study tests an experimental oral drug called IMM-1-104 in people with advanced solid tumors that have RAS mutations. The goal is to find safe doses and see if the drug can shrink tumors, either alone or with other treatments. About 209 adults with pancreatic cancer, melanoma…
Phase: PHASE1, PHASE2 • Sponsor: Immuneering Corporation • Aim: Disease control
Last updated May 01, 2026 16:01 UTC